about
QTc prolongation by psychotropic drugs and the risk of Torsade de PointesCardiovascular considerations in antidepressant therapy: an evidence-based reviewGenome-wide association analysis identifies 13 new risk loci for schizophreniaEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentAssessing QT interval prolongation and its associated risks with antipsychotics.Sudden death of cardiac origin and psychotropic drugsThe 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statementsTwo four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study.The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial.Differential changes in QTc duration during in-hospital haloperidol use.Comparative cardiovascular safety of risperidone and olanzapine, based on electrocardiographic parameters and blood pressure: a prospective open label observational study.The genomics of schizophrenia: update and implications.Response of i(kr) and HERG currents to the antipsychotics tiapride and sulpiride.Dysrhythmogenic potential in acute admissions to psychiatric hospitals and clinics.Selective acquired long QT syndrome (saLQTS) upon risperidone treatment.Atypical antipsychotic drugs in the treatment of delusional parasitosis.Off-Label Prescribing by Psychiatrists: What is the Practitioner's Liability?Analysis of efficacy and side effects in CATIE demonstrates drug response subgroups and potential for personalized medicineQT prolongation and torsades de pointes with psychotropic agentsCurrent schizophrenia drugs: efficacy and side effects.Antidepressants and QTc prolongation.Off-label use of antipsychotics: are we mad?Hypothermic overdose, not all bad?Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort studyQT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions.Antipsychotic drug toxicology in children.Probable quetiapine-mediated prolongation of the QT interval.An integrated clinical pharmacology approach for deriving dosing recommendations in a regulatory setting: review of recent cases in psychiatry drugs.A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia.'Natural' and 'Unnatural' medical deaths and coronial law: A UK and international review of the medical literature on natural and unnatural death and how it applies to medical death certification and reporting deaths to coroners: Natural/Unnatural dElectrocardiographic monitoring for new prescriptions of quetiapine co-prescribed with acetylcholinesterase inhibitors or memantine from 2005 to 2009. A population study on community-dwelling older people in Italy.In-Hospital Haloperidol Use and Perioperative Changes in QTc-Duration.Psychopathology Related to Energy Drinks: A Psychosis Case ReportQuetiapine-Induced Bradycardia Without QT Interval Prolongation in an Elderly Woman.Cardiac risk and schizophrenia.Quetiapine-induced reversible sick sinus syndrome.Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar affective patients on valproate or lithium-valproate maintenance therapy with healthy controls.Antipsychotic exposure prior to acute myocardial infarction in patients with serious mental illness.Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.
P2860
Q27015763-0BD95C3B-6681-4062-B07A-A7A43497CC98Q27021843-25F463AA-A473-49FD-9F8B-B305409F3774Q28297287-F6B0F9A6-2FE4-47A9-B824-2BD32990DC88Q28972478-9A6C0139-F502-4B62-A9E2-C822813384F1Q33160123-CBBBC732-F739-4915-ADF0-1688F5718CADQ33161295-C6520B84-0564-473F-A952-8DB66DC7D37CQ33566124-3EF40165-980B-41B7-87E5-FD8563E6CD74Q33933939-CD63B71B-708E-4AA9-893A-6CFC7C2B4B05Q33950948-464B6D10-F0E2-45A4-95F8-B3B778194330Q34035769-9F9768F9-F3DA-4DB9-965E-0A493AEB054DQ34247635-9F01EF76-4005-43BA-84A8-9A667BCBEA14Q34381708-E7CAAEA6-2095-482A-BF4D-29A33302AB00Q34382021-A2F09A21-A43A-4945-A061-BA0773573E8EQ34424791-95CF7975-7B01-412F-8475-C7FEC687A3FDQ34502554-88E08EBE-3501-454C-905B-628A96ABF2EAQ34654916-3CDAA7F7-C480-4A6E-979D-90FAEC372048Q34672146-5620EBEF-56C1-4784-9EA2-F9EADB79923CQ35375788-DD4AD535-0D6D-45B8-AB77-0DA2D897876FQ36216816-21C4C29B-7C3C-4CD4-97EC-B506306E3E22Q36488206-2C916C81-05B0-4364-A81B-B451437BF4E9Q36636333-ACE22858-6FB0-4A4D-91A3-D9F8AD0C41F4Q36945015-52A8095D-7308-4821-BCFC-1088A6852458Q37102680-9E8A63A9-7108-4BAF-8BD2-0AC5C10569C2Q37156481-F399850C-D95D-486C-912A-3288C59C3988Q37177773-7D9448A9-B5F5-4B76-A471-06F34FAB4480Q37727223-2A94586C-338C-4707-ABCE-038D14A905D1Q37852719-967E5F49-2508-48E4-BC18-2DD6D1B53A3EQ37918068-C3A2145A-8A23-43A9-8E9B-449D4B48872EQ38120678-4605F72E-46BB-492E-BC27-AA0B5AD7B2F2Q38150568-87A2E9F5-2C81-4F30-8660-AB30E7B532ACQ39409451-E0706ACD-0D5F-4930-83BE-113A7B0EBF0DQ40223168-4710E44A-B6E9-4B7D-BCA6-5E68BD568700Q40999761-5562A28F-A67E-4DE7-8104-00280E8BD291Q42330287-DEF0DD4A-6789-45D3-A097-89C21E84A7D1Q42541912-B87CF2B3-891E-4855-8F3E-D02B4CD2AD98Q42636835-FF664F17-33E7-4500-922A-B47AE5ADFE29Q42960761-A33A8960-255D-44FD-A858-69621758B15BQ46565063-F634B4DE-0D79-4066-B476-FDAD5230C30DQ50617989-624B20AB-3D63-418F-8211-4F33E5EBDC4BQ51507196-1D3D0DA7-13B3-4CF2-9AAF-816005275394
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antipsychotic drugs and QT prolongation.
@ast
Antipsychotic drugs and QT prolongation.
@en
type
label
Antipsychotic drugs and QT prolongation.
@ast
Antipsychotic drugs and QT prolongation.
@en
prefLabel
Antipsychotic drugs and QT prolongation.
@ast
Antipsychotic drugs and QT prolongation.
@en
P1476
Antipsychotic drugs and QT prolongation.
@en
P2093
Johannes O Huber
Josef Finsterer
P304
P356
10.1097/01.YIC.0000166405.49473.70
P577
2005-09-01T00:00:00Z